Guardion Health Sciences, Inc.
GHSIDelisted Oct 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001642375
Guardion Health Sciences, Inc. was delisted on Oct 11, 2024; its insiders filed their last Form 4 on Aug 28, 2024; 15 institutions reported holding it in 13F filings for Q3 2024, worth $587.7K in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Guardion Health Sciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q3 2022
- Shares held
- 3.75M
- −1.03M (−21.6%) vs. Q3 2022
- Total value
- $545.8K
- −$113.2K (−17.2%) vs. Q3 2022
- New holders
- 4
- 3 more added
- Sold out
- 5
- 4 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 15 | $587.7K |
| Q2 2024 | 12 | $674.9K |
| Q1 2024 | 12 | $595.0K |
| Q4 2023 | 11 | $347.9K |
| Q3 2023 | 14 | $497.7K |
| Q2 2023 | 13 | $387.4K |
| Q1 2023 | 10 | $314.5K |
| Q4 2022 | 22 | $545.8K |
| Q3 2022 | 23 | $659.0K |
| Q2 2022 | 22 | $654.3K |
| Q1 2022 | 20 | $1.09M |
| Q4 2021 | 20 | $1.61M |
| Q3 2021 | 19 | $3.82M |
| Q2 2021 | 16 | $4.80M |
| Q1 2021 | 14 | $4.14M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Guardion Health Sciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 300 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 420 | $61 | 0.00% | +11+2.7% | Added |
| Federation des caisses Desjardins du Quebec | 834 | $121 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 996 | $145 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 36 | $252 | 0.00% | +36 | New |
| Raymond James Financial Services Advisors, Inc. | 15,000 | $2.18K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 18,617 | $2.70K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 22,005 | $3.00K | 0.00% | +22,005 | New |
| Jane Street Group, LLC | 27,761 | $4.03K | 0.00% | +27,761 | New |
| Morgan Stanley | 33,136 | $4.81K | 0.00% | +14,210+75.1% | Added |
| Citadel Advisors LLC | 46,871 | $6.80K | 0.00% | +46,871 | New |
| Tower Research Capital LLC (TRC) | 44,945 | $7.00K | 0.00% | +6,371+16.5% | Added |
| Northern Trust Corp | 57,649 | $8.37K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 117,507 | $17.1K | 0.00% | −175,133−59.8% | Reduced |
| State Street Corp | 134,934 | $19.6K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 152,585 | $22.9K | 0.00% | −110.0% | Reduced |
| Geode Capital Management, LLC | 169,865 | $25.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 196,476 | $29.0K | 0.00% | −620,421−75.9% | Reduced |
| Barclays PLC | 250,000 | $36.3K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 288,281 | $41.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 501,454 | $72.8K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,670,750 | $242.0K | 0.00% | −53,200−3.1% | Reduced |
| Ergoteles LLC | 0 | $0 | 0.00% | −137,705−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −79,277−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −44,856−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −25,164−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −13,705−100.0% | Sold out |